Clinical Trial

Safety and Feasibility of Preoperative and Intraoperative Image-Guided Resection of Gliomas

Completed Early Phase 1
View on ClinicalTrials.gov →
Summary
This study evaluates the use of specialized magnetic resonance imaging (MRI) techniques including magnetic resonance (MR) perfusion and 2-hydroxyglutarate (2HG) spectroscopy in the surgical treatment of gliomas. Cohort 1 participants will undergo an MR perfusion scan or 2-HG spectroscopy prior to surgery and intra-operatively. Cohort 2 participants will only undergo standard of care imaging and tumor acquisition. Participant participation will end at the completion of surgery and will be transitioned to standard of care follow-up.
Protocol Amendment History 3 changes
critical Trial completed 2026-08-11
critical Phase changed: not applicable -> Early Phase 1 2026-08-11
minor Completion moved earlier: 2026-07 -> 2025-05-14 2026-08-11
Trial Details
NCT Number NCT03542409
Lead Sponsor University of Utah
Conditions Brain Tumor Adult
Enrollment 53 participants
Start Date 2017-02-15
Primary Completion 2021-10-28 (estimated)
Study Completion 2025-05-14 (estimated)
Updated on ClinicalTrials.gov 2026-08-10